ENANTA PHARMACEUTICALS, INC Property, Plant and Equipment, Gross
ENANTA PHARMACEUTICALS, INC (ENTA) had Property, Plant and Equipment, Gross of $59.20 million as of 2025-09-30, per its 10-K filed 2025-11-19.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2025-11-19
- 2025-09-30: Property, Plant and Equipment, Gross $59.20M.
- 2025-06-30: Property, Plant and Equipment, Gross $59.14M.
- 2025-03-31: Property, Plant and Equipment, Gross $58.90M.
- 2024-12-31: Property, Plant and Equipment, Gross $57.50M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-09-30 | $59.20M 10-K · filed 2025-11-19 |
| 2025-06-30 | $59.14M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $58.90M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $57.50M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $57.73M 10-K · filed 2025-11-19 |
| 2024-06-30 | $50.26M 10-Q · filed 2024-08-07 |
| 2023-09-30 | $35.66M 10-K · filed 2024-11-27 |
| 2022-09-30 | $28.03M 10-K · filed 2023-11-22 |
| 2021-09-30 | $24.87M 10-K · filed 2022-11-23 |
| 2020-09-30 | $24.27M 10-K · filed 2021-11-24 |
| 2019-09-30 | $23.11M 10-K · filed 2020-11-25 |
| 2018-09-30 | $17.47M 10-K · filed 2019-11-27 |
| 2017-09-30 | $15.10M 10-K · filed 2018-11-29 |
| 2016-09-30 | $13.10M 10-K · filed 2017-12-11 |
| 2015-09-30 | $10.16M 10-K · filed 2016-12-09 |
| 2014-09-30 | $5.94M 10-K · filed 2015-12-11 |
| 2013-09-30 | $5.46M 10-K · filed 2014-12-11 |
| 2012-09-30 | $5.15M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |